WELCOME TO EXOSOMICS

A Life Changer in Liquid Biopsy Cancer Diagnostic

Learn More

Early screening

We harvest the potential of two fundamental indicators of cancer:
tumor metabolism and extracellular vesicles

Learn More

Services

We provide high quality services to support fundamental and streamlined EV research
Learn More

People

Meet the Exosomics Team

Learn more
~

our Mission

Our mission is to develop and commercialize a new generation of tests for cancer screening and liquid biopsy, based on analysis of circulating extracellular vesicles and exosomes.

our vision

A world in which a simple blood draw will be sufficient to perform a cancer diagnosis and monitoring, enabling physicians to select the best treatment for each patient.

our values

Caring with Honesty – High Standards – Making a Difference Through Innovative Thinking – Teamwork – Partnership and Trust

Exosomics’ strengths

non-invasive

We provide true tumor biopsy in a routine blood sample, truly suitable for low interval screening and for active surveillance and monitoring.

ACCURATE

We rely on a unique biological principle and evolving science to build and fully validate highly sensitive and specific diagnostic tests.

}

EARLY

Our approach is based on fundamental drivers of cancer (e.g. metabolic switch) and exosomes as early sentinels of tumor growth.

AFFORDABLE

Our tests are simple, reliable, and cost-effective; we offer scalable and familiar test formats and provide them as an open platform tools .

OUR INVESTORS

Current investors are: Lonza, BioBalt Holding, BioFund, FinBiotech Srl, and Black Swan Trade Ltd.